Goldman Sachs analyst Salveen Richter reiterated a Conviction Buy rating and $350.00 price target on Amgen (NASDAQ: AMGN)The analyst comments ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Amgen (AMGN) PT Raised to $307 at UBSMay 3, 2024 7:06 AM Amgen (AMGN) PT Lowered to $328 at RBC CapitalMay 3, 2024 6:35 AM Amgen (AMGN) stock soars on positive obesity drug update, analyst raises PTMay 3, 2024 5:48 AM Barclays Upgrades Amgen (AMGN) to EqualweightMay 3, 2024 2:40 AM Form 4 AMGEN INC For: Apr 30 Filed by: Miller DerekMay 2, 2024 8:02 PM Form 4 AMGEN INC For: Apr 30 Filed by: Khosla RachnaMay 2, 2024 8:01 PM Form 4 AMGEN INC For: Apr 30 Filed by: Graham Jonathan PMay 2, 2024 7:59 PM Form 8-K AMGEN INC For: May 02May 2, 2024 4:04 PM Amgen (AMGN) Tops Q1 EPS by 7c; offers guidanceMay 2, 2024 4:03 PM Amgen 'encouraged' by weight-loss drug interim data, shares jumpMay 2, 2024 4:02 PM AMGEN REPORTS FIRST QUARTER 2024 FINANCIAL RESULTSMay 2, 2024 4:01 PM Arrowhead Pharmaceuticals Earns $50 Million Milestone from Royalty PharmaMay 2, 2024 4:01 PM Powell speech, Apple results, OECD growth - what's moving marketsMay 2, 2024 4:40 AM Amgen (AMGN) May weekly 277 straddle into quarter results May 2, 2024 2:52 AM Form 4 AMGEN INC For: Apr 30 Filed by: Grygiel Nancy A.May 1, 2024 8:44 PM Form 4 AMGEN INC For: Apr 30 Filed by: Santos EstebanMay 1, 2024 7:56 PM Form 4 AMGEN INC For: Apr 30 Filed by: REESE DAVID MMay 1, 2024 7:55 PM Form 4 AMGEN INC For: Apr 30 Filed by: Griffith Peter H.May 1, 2024 7:54 PM Form 4 AMGEN INC For: Apr 30 Filed by: Gordon MurdoMay 1, 2024 7:52 PM Form 4 AMGEN INC For: Apr 30 Filed by: Busch Matthew C.May 1, 2024 7:51 PM Form 4 AMGEN INC For: Apr 30 Filed by: Bradway Robert AMay 1, 2024 7:50 PM